The award-winning saves time, money and improves patient safety with an extraordinarily simple and effective innovation. Reducing drug errors, drugs stay with the patient in hospital and ambulance staff spend less time looking for medicines. It has become universal and immediately recognisable across all the hospitals that have adopted it.
Semen analysis remains one of the few areas of laboratory medicine with little or no automation, relying on training and technique to provide accurate test results. Led by Dr Mathew Tomlinson, a team at NUH has created a new computerised video tracking process that is helping Nottingham’s NHS fertility service improve standards and increase patient throughput.
The Nottingham Prognostic Index Plus (NPI+) is an award winning decision making tool for clinicians to offer personalised medicine to all female patients with breast cancer. NPI+ builds considerably upon the original NPI that was developed in Nottingham in the early 1980s. NPI+ includes ground breaking functionality by predicting both clinical outcomes (survival) and by aiding customised therapeutics. NPI+ can be used for all female breast cancer patients, not just those who are oestrogen receptor positive.